The research peptide market lacks regulatory oversight, creating conditions in which product quality varies dramatically between vendors. Researchers sourcing peptides must evaluate vendor credibility independently. This guide outlines the key indicators of vendor legitimacy.
Red Flags
No third-party COAs A vendor that cannot produce independently verified Certificates of Analysis for their products should be disqualified immediately. In-house testing — where the vendor tests their own products — provides no meaningful quality assurance. Only COAs from independent, accredited laboratories carry evidentiary weight.
Unverifiable COAs Legitimate labs provide unique certificate IDs and verification portals where researchers can confirm the COA is genuine. A COA that cannot be independently verified may be fabricated. Always verify directly with the issuing laboratory.
Vague compound descriptions Professional research suppliers provide precise compound specifications: molecular weight, amino acid sequence where applicable, storage requirements, and purity specifications. Vague descriptions ("high quality," "pharmaceutical grade" without documentation) are a warning sign.
No contact information or anonymous operation While some degree of operational discretion is common in this market, vendors with no verifiable contact information, no support channel, and no traceable business identity represent elevated risk.
Prices significantly below market Research-grade synthesis, third-party testing, and proper lyophilization have real costs. Pricing dramatically below market rates typically reflects corners cut somewhere in the production or quality control process.
No research disclaimer Legitimate research peptide vendors include clear "For Research Use Only / Not for Human Consumption" disclaimers on all products and pages. Absence of this language may indicate non-compliance with accepted vendor standards.
Green Flags
Independent third-party COAs with verifiable certificates COAs from accredited independent laboratories — with unique report numbers, scientist signatures, and verification portals — are the strongest indicator of product legitimacy.
Specific purity and potency data Results showing HPLC purity ≥98% and potency within 95-105% of label claim, accompanied by chromatograms, demonstrate rigorous quality control.
Transparent communication Responsive vendors who answer compound-specific questions accurately and acknowledge the limitations of their products demonstrate operational credibility.
Established community presence Vendors with documented track records in research communities, consistent product reviews, and verifiable customer history present lower risk than anonymous new entrants.
Professional site and documentation While aesthetics alone are not determinative, a professionally maintained website, consistent legal documentation, and coherent product information suggest an operation with some level of organizational investment.
Researchers should treat vendor selection with the same rigor applied to any other aspect of experimental design. Compound quality directly affects data quality.